Clinical parameters associated with anti-programmed death-1 (PD-1) inhibitors-induced tumor response in melanoma patients.
- DOI
- 10.1007/s10637-017-0476-6
- Published
- 2017 Dec
- Container
- Investigational new drugs
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10637-017-0476-6,
title = {Clinical parameters associated with anti-programmed death-1 (PD-1) inhibitors-induced tumor response in melanoma patients.},
author = {Heidelberger V and Goldwasser F and Kramkimel N and Jouinot A and Franck N and Arrondeau J and Guégan S and Mansuet-Lupo A and Alexandre J and Damotte D and Avril MF and Dupin N and Aractingi S},
year = {2017},
journal = {Investigational new drugs},
doi = {10.1007/s10637-017-0476-6},
url = {https://doi.org/10.1007/s10637-017-0476-6}
}RIS
TY - JOUR TI - Clinical parameters associated with anti-programmed death-1 (PD-1) inhibitors-induced tumor response in melanoma patients. AU - Heidelberger V AU - Goldwasser F AU - Kramkimel N AU - Jouinot A AU - Franck N AU - Arrondeau J AU - Guégan S AU - Mansuet-Lupo A AU - Alexandre J AU - Damotte D AU - Avril MF AU - Dupin N AU - Aractingi S PY - 2017 JO - Investigational new drugs DO - 10.1007/s10637-017-0476-6 UR - https://doi.org/10.1007/s10637-017-0476-6 ER -
APA
V, H., F, G., N, K., A, J., N, F., J, A., S, G., A, M., J, A., D, D., MF, A., N, D., & S, A. (2017). Clinical parameters associated with anti-programmed death-1 (PD-1) inhibitors-induced tumor response in melanoma patients.. Investigational new drugs. https://doi.org/10.1007/s10637-017-0476-6
Source records
- pubmed · retrieved 2026-09-27T10:13:25.702Z
- europe-pmc · retrieved 2026-09-27T10:13:25.706Z
- hal · retrieved 2026-09-27T10:13:25.741Z